Matches in Nanopublications for { ?s ?p "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP182571.RAcHpYPXNRXkYnhVKUIMueWF7TCcMcOvvPf8l11T7xKyA130_assertion description "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182571.RAcHpYPXNRXkYnhVKUIMueWF7TCcMcOvvPf8l11T7xKyA130_provenance.
- assertion description "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP428511.RAASzUrHKbjlH7jCLziMZqun7FDjVXL7LSHBESjlWl-04130_assertion description "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428511.RAASzUrHKbjlH7jCLziMZqun7FDjVXL7LSHBESjlWl-04130_provenance.
- NP700856.RA881Sds1emVc07ju9BGMsAt2zSWMEQsogR5a1J4As6aI130_assertion description "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700856.RA881Sds1emVc07ju9BGMsAt2zSWMEQsogR5a1J4As6aI130_provenance.
- NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_assertion description "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700881.RA56jiEdg8vg9sn7gdBUHvGfZmylBPLrGEh8qw5JaEBr8130_provenance.
- NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_assertion description "[Vesicular monoamine transporter subtype 2 (VMAT2) activity protects against neurotoxins, and reduced VMAT2 expression is implicated in drug addiction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428512.RALAU_8UIjKDjuDq7FB7wywmgBOW_4gbidKiJMQWq77lk130_provenance.